Cycclone Inc.

Cycclone Inc.

CYCL
Cycclone Inc.US flagOther OTC
0.05
USD
+0.00
- -
1.84MMarket Cap
2006 Y
2007 Y
2008 Y
2022 Y
2023 Y
TTM
Revenue per Share
0.05
- -
0.54
- -
- -
0.7
Basic EPS, GAAP
- -
-0.01
0.15
- -
- -
0.21
Free Cash Flow per Basic Share
- -
- -
0.14
- -
- -
0.33
Dividend per Share
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
-0.01
0.27
- -
- -
0.47
Tangible Book Value per Share
- -
-0.01
0.52
- -
- -
0.71
Basic Weighted Avg Shares
9
10
30
26
- -
30
Sales/Revenue/Turnover
- -
- -
16
- -
- -
21
Operating Margin (%)
-3.48
- -
31.15
- -
- -
33.59
Depreciation Expense
- -
- -
1
- -
- -
1
Net Income, GAAP
- -
- -
5
- -
-1
6
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-3.48
- -
28.47
- -
- -
30.58
Working Capital
- -
- -
7
- -
-2
13
LT Debt
- -
- -
- -
- -
- -
1
Total Equity
- -
- -
17
- -
-1
23
Return on Invested Capital (%)
- -
- -
- -
- -
- -
58.5
Return on Capital (%)
- -
- -
- -
- -
- -
57.49
Return on Common Equity (%)
- -
- -
- -
- -
- -
140.08

Capital Structure

FRC

in mil. unless spec.
Oct'07
Dec'22
Mar'22
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
1
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
30
30
30
Market Capitalization
- -
45
30

Working Capital

FRC

in mil. unless spec.
Oct'07
Dec'22
Mar'22
Total Current Assets
- -
12
15
Cash, Cash Equivalents & STI
- -
8
10
Accounts Receivable, Net
- -
3
4
Inventories
- -
- -
- -
Total Current Liabilities
- -
1
2
Payables & Accruals
- -
1
2
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
3,946.02%
Free Cash Flow
- -
- -
-105.74%
Net Income, GAAP
- -
- -
-120.84%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
5
6
5
- -
- -
2023
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
0.04
0.06
0.04
- -
- -
2023
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Michael Nugent
Full Time Employees
689
Sector
Financial Services
Industry
Shell Companies
Address
Building B Lanzhou QL People's Republic of China 730000
IPO Date
Feb 13, 2008
Business
Cycclone Inc. is a biotechnology and agricultural products company focused on the development and commercialization of bacteria-based products for livestock, crop production, and related applications; it operates through artificial microorganism and high-efficiency microorganism blends, biological preservatives, and fertilizer products, with additional involvement in agricultural and animal science preservation, and real estate investments. Main products and services - Bacteria-based additives for livestock feed and crop cultivation, including artificial microorganisms (AM) and high-efficiency microorganism (HM) blends; formulations aim to improve growth, digestion, yield, and soil health - Biological preservatives and FGW bacterial-based preservatives for preserving animal specimens for research and maintaining freshness of agricultural produce - Bacteria-based fertilizers for plant applications, including leaves of vegetables and fruits - Real estate investment activities comprising residential and commercial properties Latest major company changes - Name and corporate structure: formerly known as China Dasheng Biotechnology Co.; changes its corporate name to Cycclone Inc. in 2025 reflecting a broader biotechnology and agri-food focus - Strategic and product developments: expansion of bacteria-based product lines and preservation solutions; continued development of AM/HM technologies and preservative products for research and agricultural use - Corporate activity: public reporting and listing activities on over-the-counter markets; ongoing optimization of product registrations and regulatory compliance within biotechnological and agricultural segments Industry context and segments - Industry: specialty biotech and agricultural biotechnology; niche segments include microbial products for animal nutrition, crop productivity enhancers, and biological preservatives - Business segments: livestock feed additives, crop production additives, preservation solutions, plant-based fertilizers, and real estate investment activities - Target markets: livestock producers, farmers, agribusinesses, research institutions, and potential commercial customers seeking microbial solutions; geographic emphasis on China with broader international exposure as regulatory and market access allow - Corporate relationships: operates as Cycclone Inc. with subsidiaries or affiliated entities; reorganizations reflect a shift from original branding to a broader biotech and agri-biotech platform Founding and domicile - Founded: 2004 - Headquarters: Lanzhou, People’s Republic of China Subsidiaries and affiliations - The company maintains corporate structures and potential subsidiaries aligned with its biotech and agri-biotech product lines and may engage in related real estate investments as part of its diversified holdings Notes - Information reflects publicly available descriptions of Cycclone Inc. and its product scope, with emphasis on its core bacteria-based products, preservation solutions, plant fertilizers, and its recent corporate name change and expansion into broader biotech activities - Investors should review the company’s most recent filings and disclosures for up-to-date financials, regulatory status, and strategic initiatives

Company News

APIChatGPT
  • Cycclone, Inc. Announces Agreement in Principle for the Acquisition of AI Robotics Company

  • CDBT Registers Magistrates Court of Queensland Judgments against Kenneth Maciora / Empire Relations Group

  • CDBT - Terminates Consulting Agreement with Kenneth Maciora / Empire Relations Group

  • CDBT - Cycclone Magnetic Engines